Deerland Enzymes launches new products to tackle food intolerances

By Stephen DANIELLS

- Last updated on GMT

Lactose intolerance affects over one-third of Americans
Lactose intolerance affects over one-third of Americans

Related tags: Coeliac disease

Leading enzyme-based dietary supplement formulator has released two new products targeting gluten and lactose intolerance, conditions that affect over one third of the US population.

Over 33% of the US population is reported to be lactose intolerant. About 1% of the US people is reported to have Celiac Disease, although 6-7% of the population are thought to have ‘non-celiac gluten sensitivity’, according to the Gluten Intolerance Group.

“Food intolerances and food-driven immune responses are becoming more and more recognized by consumers,”​ said Scott Ravech, CEO of Deerland Enzymes. 

“Gluten and dairy intolerances are especially good candidates for enzyme-based solutions like Dairylytic and Glutalytic. Supplementation may lead to fewer dietary restrictions, which can yield huge quality of life benefits.”

The products were launched at the recent Engredea/Expo West Tradeshow in Anaheim, CA, and initial feedback has been “positive”​, said Ravech.

“By confirming our research showing that sensitivity to dairy could just as easily be driven by an immune response to protein as lactose intolerance, we’re confident that we’re headed in the right direction.”

Product breakdown

Dairylytic is described by Deerland as a “dual-functioning enzyme blend formulated with a combination of both lactose and a unique protease enzyme blend developed solely for superior protein degradation”​.

Dr. John Deaton, VP of Technology at Deerland Enzymes, explained that many people who experience digestive discomfort from consuming dairy products assume they are lactose intolerant, but still do not find relief using traditional lactase enzyme supplements.

“Their discomfort may actually be attributed to an immune response from the protein components of dairy, not intolerance to the lactose,” ​he said.

Glutalytic also goes beyond traditional DPPIV (dipeptidyl peptidase IV) enzymes, said the company, by targeting the internal and external peptide bonds that make up the gluten protein.

“The fastest way to break down gluten is to cleave peptide bonds internally and externally,”​ said Deaton. “Glutalytic contains both endopeptidases and exopeptidases to create the correct endopeptidase cleavage pattern near the long chain amino acids that need to be hydrolyzed by the exopeptidase, producing rapid degradation of gluten.”

Kristin Wilhoyte, Marketing Communications Manager for Deerland Enzymes, told us the ingredients can be used in customizable formulations. Glutalytic is not intended to replace a gluten-free diet, but is a supplements to a gluten-free diet to avoid the problems associated with accidental contamination, for example, she said.   

Related news

Related products

show more

Fermented Soy for Relief of Heartburn Symptoms

Fermented Soy for Relief of Heartburn Symptoms

Lallemand Bio-Ingredients | 08-Oct-2020 | Clinical Study

Gastro-AD® is a food supplement based on non-GMO soy fermented by Lactobacillus strain L. delbrueckii R-187 (Rosell-187). It has an excellent track record...

Biotis™ - Solutions for a good gut feeling

Biotis™ - Solutions for a good gut feeling

FrieslandCampina Ingredients | 07-Oct-2020 | Product Brochure

Discover our range of GOS (galacto-oligosaccharides) with scientifically proven effects to significantly increase levels of ‘friendly bacteria’ in the...

Discover adaptive exercise recovery with Restoridyn

Discover adaptive exercise recovery with Restoridyn

Verdure Sciences | 28-Sep-2020 | Technical / White Paper

Looking for an ingredient to support active and healthy individuals of various levels of skill and exercise intensity to meet the changing needs of sports...

Supporting cardiovascular health with probiotics

Supporting cardiovascular health with probiotics

Deerland Probiotics & Enzymes | 03-Aug-2020 | Technical / White Paper

Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of cardiovascular disease. Evidence exists...

Related suppliers

Follow us

Products

View more

Webinars